Innate immunity against vaccinia virus is mediated by TLR2 and requires TLR-independent production of IFN-beta.
about
Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKepsilon-mediated IRF activationPhosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammationInnate immune sensing of DNA virusesToll-like receptors in antiviral innate immunityDeletion of the vaccinia virus gene A46R, encoding for an inhibitor of TLR signalling, is an effective approach to enhance the immunogenicity in mice of the HIV/AIDS vaccine candidate NYVAC-CTranslational mini-review series on Toll-like receptors: recent advances in understanding the role of Toll-like receptors in anti-viral immunityToll-Like Receptors and Viruses: Induction of Innate Antiviral Immune ResponsesInnate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasomeProtective effect of Toll-like receptor 4 in pulmonary vaccinia infectionDirect TLR2 signaling is critical for NK cell activation and function in response to vaccinia viral infection.Antiangiogenic arming of an oncolytic vaccinia virus enhances antitumor efficacy in renal cell cancer models.Murine toll-like receptor 2 activation induces type I interferon responses from endolysosomal compartmentsTargeting a mimotope vaccine to activating Fcgamma receptors empowers dendritic cells to prime specific CD8+ T cell responses in tumor-bearing mice.Boosting functional avidity of CD8+ T cells by vaccinia virus vaccination depends on intrinsic T-cell MyD88 expression but not the inflammatory milieu.Involvement of TLR2 in recognition of acute gammaherpesvirus-68 infection.Toll-like receptor 8-mediated activation of murine plasmacytoid dendritic cells by vaccinia viral DNAInnate immune recognition of viruses and viral vectors.Type I interferons mediate the innate cytokine response to recombinant fowlpox virus but not the induction of plasmacytoid dendritic cell-dependent adaptive immunity.Toll-like receptor agonists: are they good adjuvants?Functional divergence among CD103+ dendritic cell subpopulations following pulmonary poxvirus infection.NK cell-extrinsic IL-18 signaling is required for efficient NK-cell activation by vaccinia virus.The Split Virus Influenza Vaccine rapidly activates immune cells through Fcγ receptors.A novel HIV vaccine adjuvanted by IC31 induces robust and persistent humoral and cellular immunity.Role of type I interferon receptor signaling on NK cell development and functionsCXCL12/CXCR4 blockade by oncolytic virotherapy inhibits ovarian cancer growth by decreasing immunosuppression and targeting cancer-initiating cells.Immunization with a recombinant vaccinia virus that encodes nonstructural proteins of the hepatitis C virus suppresses viral protein levels in mouse liverTRAM is required for TLR2 endosomal signaling to type I IFN inductionA novel TLR3 inhibitor encoded by African swine fever virus (ASFV).Interplay between modified vaccinia virus Ankara and dendritic cells: phenotypic and functional maturation of bystander dendritic cells.Novel drugs targeting Toll-like receptors for antiviral therapy.Contemplating the Importance of Toll-like Receptors I and II Regarding Human Viral Pathogenesis.dsRNA sensors and plasmacytoid dendritic cells in host defense and autoimmunity.NK cell response to vaccinia virus is regulated by myeloid-derived suppressor cells.Commensal bacteria lipoteichoic acid increases skin mast cell antimicrobial activity against vaccinia viruses.CD8 marks a subpopulation of lung-derived dendritic cells with differential responsiveness to viral infection and toll-like receptor stimulation.High-dimensional gene expression profiling studies in high and low responders to primary smallpox vaccination.Impact of infection or vaccination on pre-existing serological memoryNatural Killer Cells and Innate Interferon Gamma Participate in the Host Defense against Respiratory Vaccinia Virus Infection.Virotherapy, gene transfer and immunostimulatory monoclonal antibodies.Survival of lethal poxvirus infection in mice depends on TLR9, and therapeutic vaccination provides protection
P2860
Q24315019-705DF14C-5FE5-4424-BF3F-287E11B5E749Q24338129-D0EB31F5-B7E6-4CAF-95B6-2DC50AFEC9CAQ24626598-96BC0D9C-BFBA-40A2-82A0-39CA1BDEC1B6Q27011462-7DBDEC98-F216-4301-93C9-BA4527DC28C7Q27306437-A3312987-4579-4C25-9B41-0D2CB14D1918Q27478142-29CEA496-2A2C-4C51-845A-5D2C109B97D5Q27487393-D0223689-EFE7-4A66-B046-20D8F8733824Q28389050-0E32972F-DEFF-4EF4-AFDE-575EA7D4BA7FQ33370547-14BE8A46-2F70-416F-A2D0-A0AF947D89ADQ33543131-80C7315C-B888-4FC8-85AD-671ECD38BD42Q33558337-06F5FD06-5ECF-43FC-8F41-3B36657496B7Q33565626-65A83F6B-9739-40AF-A0BF-8FE6F1013667Q33584637-CF204479-35D8-4EF9-9EFA-4ACDB0B2CA2AQ33602726-86D9E13B-ABE8-4048-A3D2-7954EEF16847Q33741907-028775F4-803B-4617-B981-712815929F59Q33778828-5114C654-2713-4394-9647-03375DCFAC63Q33805229-BB0993E8-F52B-4E28-A379-111CF0A8AB1FQ33990693-7D5AA05D-F400-4BE8-B34E-CB90607262CCQ34067537-4917F312-963D-4A07-9020-11F64434BE39Q34120821-A0E55495-5902-41A2-8C5D-CD2A2A980B2DQ34195250-3F619442-3D1E-49BF-AD3C-AC2F8A54F08DQ34313957-B297DBC0-9F46-4AF0-B97C-34920903E74DQ34359593-C27F0721-9844-401F-8374-BF5056782E4FQ34380402-EFF93071-F083-48FD-962B-D2A208D009AAQ34476278-9256D124-0D1D-4A09-95F4-0350A3BF0039Q34532114-01678503-88A2-43E4-92A3-898AE6B63D64Q34646268-FB335615-DAE4-4EB7-ABAB-25002DCAC1D5Q34733934-18F7ED95-58E1-47EA-ABD5-9D84C377C2C6Q34982651-8015EB9D-6B58-4049-BFF3-B27B49270670Q34999938-AB05514E-F69B-4E2D-89D7-4783C630BF56Q35132019-6DE0DFC5-239D-4763-AC2A-DB5052354822Q35205757-77BCB5E6-714A-42DD-BFBE-0CC7B507D00EQ36139822-1231ED60-BFCA-47B7-A67C-B35B302A545AQ36139858-21932036-8F97-412C-AF17-58B2E1C7DECEQ36276652-6CB62BFB-4AD7-45FF-8F1B-FF7C6DBF5A11Q36330959-5BA1AAB6-63FF-4802-A37D-2F2E7CDFABFCQ36339034-4966993A-8D6E-4645-BBE1-39C13A022E63Q36433932-74554AEE-5A2B-4D44-A010-11D66F8F7DBAQ36456487-078ABAC6-B3AC-4D0E-AC6E-D1A682670816Q36532515-11749AB6-307B-4517-9D1B-4F91695DC4C8
P2860
Innate immunity against vaccinia virus is mediated by TLR2 and requires TLR-independent production of IFN-beta.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Innate immunity against vaccin ...... endent production of IFN-beta.
@ast
Innate immunity against vaccin ...... endent production of IFN-beta.
@en
type
label
Innate immunity against vaccin ...... endent production of IFN-beta.
@ast
Innate immunity against vaccin ...... endent production of IFN-beta.
@en
prefLabel
Innate immunity against vaccin ...... endent production of IFN-beta.
@ast
Innate immunity against vaccin ...... endent production of IFN-beta.
@en
P2093
P2860
P1433
P1476
Innate immunity against vaccin ...... endent production of IFN-beta.
@en
P2093
Jennifer Martinez
Jiangao Zhu
Xiaopei Huang
Yiping Yang
P2860
P304
P356
10.1182/BLOOD-2006-06-027136
P407
P577
2006-09-14T00:00:00Z